comparemela.com
Home
Live Updates
New Co Investoren - Breaking News
Pages:
Latest Breaking News On - New co investoren - Page 1 : comparemela.com
64 Millionen Euro zur Entwicklung RNA-basierter Therapien gegen Herzerkrankungen
Cardior Pharmaceuticals hat eine Serie-B-Finanzierung in Höhe von 64 Millionen Euro (USD 76 Millionen) abgeschlossen. Lead-Investor ist Inkef Capital, neue Co-Investoren sind Fund+, Sunstone, Hade .
Thomas thum
University hanover
Research of prof
Bristol myers squibb
Development of cdr
Company in ascenions
Cardior pharmaceuticals
Euros for
Rna basierter therapies
New co investoren
Hadean ventures
Its active ingredient
Disease will
Medical university hanover
Cardior opens
Research thrown
vimarsana © 2020. All Rights Reserved.